Radiotherapy for nasopharyngeal cancer

Cancer Radiother. 2022 Feb-Apr;26(1-2):168-173. doi: 10.1016/j.canrad.2021.08.009. Epub 2021 Dec 22.

Abstract

Nasopharyngeal cancers are a rarity in France. Radiotherapy is the cornerstone of treatment, frequently combined with chemotherapy. The technical modality of radiotherapy is complex in this disease, which is located in the vicinity of numerous organs at risk. In this article, we will present the updated guidelines of the French society for radiation oncology (Société française de radiothérapie oncologique, SFRO) on the indications, and technical details of radiotherapy in nasopharyngeal cancers.

Keywords: Cancer du nasopharynx; Chemotherapy; Chimiothérapie; Guidelines; Nasopharyngeal cancer; Radiotherapy; Radiothérapie; Recommandations; Société française de radiothérapie oncologique.

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • France
  • Humans
  • Nasopharyngeal Neoplasms / diagnostic imaging
  • Nasopharyngeal Neoplasms / drug therapy
  • Nasopharyngeal Neoplasms / radiotherapy*
  • Organs at Risk / diagnostic imaging
  • Radiation Oncology
  • Rare Diseases / radiotherapy
  • Societies, Medical